Matzim LA
NDC 52544-695, Diltiazem Hydrochloride, tablet, extended release, from Actavis Pharma, Inc..
- Product NDC
- 52544-695
- Status
- Listed
- Labeler
- Actavis Pharma, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077686
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/52544-695 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DILTIAZEM HYDROCHLORIDE420 mg/1
Pharmacologic classes
Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A4 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 52544-695-19 | 52544069519 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (52544-695-19) |
| 52544-695-30 | 52544069530 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (52544-695-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e8c8dd18-9d95-4068-9762-bec1eb1bc25cNADAC price for package 52544069519
GET /v1/drugs/nadac/52544069519NADAC price for package 52544069530
GET /v1/drugs/nadac/52544069530
Use it
Look up 52544-695 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/52544-695 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 52544-695. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.